Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2012
08/09/2012US20120202850 Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202806 Novel Pyrimidine- And Triazine-Hepcidine Antagonists
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202782 Compounds and compositions as itpkb inhibitors
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120202273 Enzymatic Conversion Of Blood Group A, B, And AB Red Blood Cells Using Alpha-N-Acetylgalactosaminidases and Alpha-Galactosidases With Unique Substrate Specificities And Kinetic Properties
08/09/2012US20120202243 IN Vivo Incorporation of Unnatural Amino Acids
08/09/2012US20120201912 Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201867 Drug delivery from embolic agents
08/09/2012US20120201864 Method
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201805 Composition for improving blood circulation and alleviating cold hands and feet, containing fermented tea extract
08/09/2012US20120201784 Long lasting drug formulations
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484697A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484369A1 Manufacturing method for dried earthworm powder
08/08/2012EP2484366A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
08/08/2012EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors
08/08/2012CN202366204U Traditional Chinese medicine bag for treating liver ascites
08/08/2012CN102628044A RNAi modulation of APOB and uses thereof
08/08/2012CN102628029A Thalassemia-induced multipotent stem cell as well as preparation method and application thereof
08/08/2012CN102627680A Ginsenoside Rg1 compound and pharmaceutical composition containing the same
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627656A Process for extraction and separation of ginkgolides A, B, C, J, M and bilobalide
08/08/2012CN102627620A One type of benzofuran derivatives and medical application thereof
08/08/2012CN102626517A Method to modulate hematopoietic stem cell growth
08/08/2012CN102626506A Traditional Chinese medicine for curing seroperitoneum
08/08/2012CN102626493A Arborvitae leaf-flos sophorae-thistle-cogongrass rhizome decoction for curing peptic ulcer bleeding
08/08/2012CN102626487A Chinese medicinal pill for treating wind-cold damp pathogen and preparation method thereof
08/08/2012CN102626472A Medicine for treating acute cerebral hemorrhage and preparation method thereof
08/08/2012CN102626462A Pharmaceutical composition with blood-enriching and leukogenic efficacy
08/08/2012CN102626450A Method for preparing total diterpenoids alkaloid in monkshood
08/08/2012CN102626449A Capsule for treating apoplexy hemiplegia
08/08/2012CN102626427A Ginkgo dipyridamole composition and preparation method of preparation thereof
08/08/2012CN102626419A Compound preparation for treating edema diseases of pigs and preparation method thereof
08/08/2012CN102626391A Aliskiren-hydrochlorothiazide drug combination liposome solid preparation
08/08/2012CN102626388A Liposome solid preparation of ozagrel
08/08/2012CN102626383A Bilobalide injection and preparation method thereof
08/08/2012CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
08/08/2012CN102205115B Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen
08/08/2012CN102167752B Preparation method of water-soluble soybean polysaccharide ferrous coordination compound
08/08/2012CN101889079B A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc
08/08/2012CN101822690B Composition of dextran 40 and sodium lactate Ringer' solution and preparation method
08/08/2012CN101590192B Traditional Chinese medicine combination for treating leukemia and preparation method thereof
08/08/2012CN101553466B New crystalline forms
08/08/2012CN101543298B Rutin chewing agent and method for preparing same
08/08/2012CN101485791B Application of Ampelopsis grossedentata total flavone in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease
08/07/2012CA2563401C Imidazole derivatives used as tafia inhibitors
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2430557C Highly branched soluble glucose polymers and process of obtaining same
08/02/2012WO2012103512A2 Expanded utility of red cell-derived microparticles (rmp) for treatment of bleeding
08/02/2012WO2012102937A2 Compounds that expand hematopoietic stem cells
08/02/2012WO2012102555A2 Fucoidan for thrombolysis, derived from seaweed
08/02/2012WO2012101747A1 Tie2 ACTIVATOR, AGENT FOR MATURING, NORMALIZING OR STABILIZING BLOOD VESSELS, AGENT FOR STABILIZING LYMPHATIC VESSELS, PREPARATION FOR PREVENTING AND REDUCING WRINKLES, AND PREPARATION FOR REDUCING AND PREVENTING SWELLING
08/02/2012WO2012101442A1 Process
08/02/2012WO2012101181A1 Compositions and methods for cell transplantation
08/02/2012WO2012100654A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof
08/02/2012US20120196924 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs
08/02/2012US20120196909 Deferacirox dispersible tablets
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196825 Compositions and methods for modulating the immune system
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120196806 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120195987 Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195965 Solid dosage form comprising a fibrate
08/02/2012US20120195910 Anti-pcsk9 antibodies and methods of use
08/02/2012US20120195908 Combinatorial therapy
08/02/2012US20120195871 Stable aqueous suspension
08/02/2012US20120195826 Injectable biomaterial
08/02/2012DE102011003315A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder
08/02/2012CA2825252A1 Compositions and methods for cell transplantation
08/02/2012CA2824931A1 Process
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481398A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects
08/01/2012EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
08/01/2012EP2188016B1 Use of octreotide as a therapeutic agent
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN102625712A Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 671